[1] |
田文,赵文新.腔镜分化型甲状腺癌根治术的难点和争议[J/CD].中华普外科手术学杂志(电子版),2018,12(6):451-454..
|
[2] |
Torresan F, Cavedon E, Mian C, et al.Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience[J]. World J Surg, 2018, 42(2): 367-375.
|
[3] |
Davies L, Welch HG. Current thyroid cancer trends in the United States[J]. JAMA Otolaryngol Head Neck Surg, 2014, 140(4): 317-322.
|
[4] |
孙辉,李世杰,付言涛.分化型甲状腺癌功能性或传统性颈淋巴结清扫的利弊[J/CD].中华普外科手术学杂志(电子版),2018,12(6):455-457.
|
[5] |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J]. Thyroid, 2016, 26(1): 1-133.
|
[6] |
陈曦,陈海珍.甲状腺乳头状癌行预防性中央区淋巴结清扫的纷争[J/CD].中华普外科手术学杂志(电子版),2018,12(6):458-461.
|
[7] |
Muller S, Senne M, Kirschniak A, et al. Impact of surgical resection extension on outcome for primary well-differentiated thyroid cancer-a retrospective analysis[J]. World J Surg Oncol, 2017, 15(1): 190-190.
|
[8] |
Sharifi A, Shojaeifard A, Soroush A, et al. Predictors of Regional Lymph Node Recurrence after Initial Thyroidectomy in Patients with Thyroid Cancer[J]. J Thyroid Res, 2016, 4127278.
|
[9] |
Dideban S, Abdollahi A, Meysamie A, et al. Thyroid papillary microcarcinoma: etiology, clinical manifestations, diagnosis, follow-up, histopathology and prognosis[J]. Iran J Pathol, 2016, 11(1): 1-19.
|
[10] |
Kiriakopoulos A, Petralias A, Linos D. Multifocal versus solitary papillary thyroid carcinoma[J]. World J Surg, 2016, 40(9): 2139-2143.
|
[11] |
Geller G, Laskin J, Cheung WY, et al. A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy[J]. Thyroid Res, 2017, 10: 6-6.
|
[12] |
Wu ZG, Yan XQ, Su RS, et al. How many contralateral carcinomas in patients with unilateral papillary thyroid microcarcinoma are preoperatively misdiagnosed as benign? [J]. World J Surg, 2017, 41(1): 129-135.
|
[13] |
Kim KJ, Kim SM, Lee YS, et al. Prognostic significance of tumor multifocality in papillary thyroid carcinoma and its relationship with primary tumor size: a retrospective study of 2, 309 consecutive patients [J]. Ann Surg Oncol, 2015, 22(1): 125-131.
|
[14] |
Pyo JS, Sohn JH, Kang G. Detection of tumor multifocality is important for prediction of tumor recurrence in papillary thyroid microcarcinoma: a retrospective study and meta-analysis[J]. J Pathol Transl Med, 2016, 50(4): 278-286.
|
[15] |
Huang G, Tian X, Li Y, et al. Clinical characteristics and surgical resection of multifocal papillary thyroid carcinoma: 168 cases[J]. Int J Clin Exp Med, 2014, 7(12): 5802-5807.
|
[16] |
Spinelli C, Strambi S, Rossi L, et al. Surgical Management of Medullary Thyroid Carcinoma in Pediatric Age[J]. Curr Pediatr Rev, 2016, 12(4): 280-285.
|
[17] |
Mishra A, Kumar C, Chand G, et al. Long-Term Outcome of Follicular Thyroid Carcinoma in Patients Undergoing Surgical Intervention for Skeletal Metastases[J]. World J Surg, 2016, 40(3): 562-569.
|
[18] |
Qu HJ, Qu XY, Hu Z, et al. The synergic effect of BRAFV600E mutation and multifocality on central lymph node metastasis in unilateral papillary thyroid carcinoma[J]. Endocr J, 2018, 65(1): 113-120.
|
[19] |
Kimbrell HZ, Sholl AB, Ratnayaka S, et al. BRAF Testing in Multifocal Papillary Thyroid Carcinoma[J]. Biomed Res Int, 2015, 2015: 486391.
|
[20] |
Iwama E, Fujimura T, Kusakari Y, et al. Multifocal BRAF(V600E)-Mutated Melanoma in situ on the Foot[J]. Case Rep Dermatol, 2015, 7(3): 322-327.
|
[21] |
Lu Z, Sheng J, Zhang Y, et al. Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles[J]. J Pathol, 2016, 239(1): 72-83.
|